In Cyvex Nutrition’s newest Vine newsletter, the company highlights a lesser-known omega-3 fatty acid, docosapentaenoic acid (DPA), and its newest weight management ingredient, SolaThin.
In Cyvex Nutrition’s newest Vine newsletter, the company highlights a lesser-known omega-3 fatty acid, docosapentaenoic acid (DPA), and its newest weight management ingredient, SolaThin.
Dubbed “the missing link,” DPA is described as an intermediary between two more popular omega-3 fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Cyvex reports that DPA can potentially reduce the risk of acute coronary events in clinical trials, protect against age-related cognitive decline, and support lipid metabolism.
“Emerging evidence now seems to indicate DPA plays a substantial role in nutritional supplementation, as it has therapeutic potential to work synergistically with EPA and DHA as a stand-alone fatty acid,” says Cyvex.
Meanwhile, Cyvex is also promoting its SolaThin pure potato protein extract. SolaThin contains a special protein called protease inhibitor PI-2, which research indicates has the ability to produce cholecystokinin, a peptide believed to produce feelings of gastric fullness.
According to Cyvex, PI-2 is backed by 20 years of university research. Clinical trials suggest that SolaThin, via PI-2, can reduce food consumption by as much as 20%.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
2 Commerce Drive
Cranbury, NJ 08512